01952.HK
Everest Medicines Limited
HKSE · Healthcare · Biotechnology · CN
HKD 27.58
+4.71%Next report
Analyst consensus
- Next report date
- Apr 1, 2027
- EPS estimate
- HKD 2.17
- Revenue estimate
- HKD 2.5B
Latest reported
- Last report date
- Aug 17, 2026
- EPS actual
- -HKD 0.02
- EPS estimate
- -HKD 1.07
- Revenue actual
- HKD 1.3B
- Revenue estimate
- HKD 1.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +97.8%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 17, 2026 | -HKD 1.07 | -HKD 0.02 | Beat 97.85% | HKD 1.3B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 1, 2027